MedicalResearch.com Interview with Caroline Watts, PhD Candidate Cancer Epidemiology and Services Research
MRV Research
Seven recent developments involving pediatric dermatology
Recent study findings involving pediatric dermatology included the potential association between moderate-to-severe atopic dermatitis with central obesity and increased blood pressure in children.
NYU Langone Researchers Find Two Molecules Able to Suppress Melanoma Spread
Researchers at NYU Langone Medical Center and NYU Langone’s Laura and Isaac Perlmutter Cancer Center recently reported their findings on two molecules of non-coding genetic material that are able to stall the spread of melanoma. The study, entitled “Identification of Metastasis-Suppressive microRNAs in Primary Melanoma,” which was published in the Journal of the National Cancer Institute, represents the largest epigenetic analysis so far focusing on cell-signaling molecules in early-stage melanoma.
Cobimetinib Receives Priority Review for Advanced Melanoma
The FDA has granted a priority review to the MEK inhibitor cobimetinib for use in combination with the BRAF inhibitor vemurafenib (Zelboraf) to treat patients with BRAF V600–positive advanced melanoma. A final approval decision will come from the FDA by August 11, 2015.